Dartsbio Pharmaceuticals

Zhongshan, China · Founded 2017 · Privately Held (backing)

Developer of antibody drugs intended to improve the quality of life for cancer patients. Dartsbio Pharmaceuticals is based in Zhongshan, China and was founded in 2017. Its last reported valuation was $15.7 million in May 2020. It has raised $36 million.

Last reported valuation
$15.7M
Oct 2026
Priced at
—
Total raised
$36.0M
Last round
—

Who backs Dartsbio Pharmaceuticals?

11 investors
InvestorType
Guangdong Yuecai Venture CapitalOther
Fuho CapitalVenture capital
Zhongshan Xiwan Investment Holding DevelopmentOther
Guangdong Gaowei Investment Management—
Jingxing Tiancheng (Ningbo) Private Equity Fund Management—
Kaitai Capital—
Nest Group (Guangzhou)—
Share Capital—
Shenzhen Qianhai Greatwall Fund—
Zhongshan Xiangshang Private Equity Investment Fund Management—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Dartsbio Pharmaceuticals investors

11 investors are on record for Dartsbio Pharmaceuticals, including Guangdong Yuecai Venture Capital, Fuho Capital, Zhongshan Xiwan Investment Holding Development and Guangdong Gaowei Investment Management.

Free account
More of Dartsbio Pharmaceuticals with a free account
  • ·The complete investor list: 11 names
  • ·Watch Dartsbio Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Dartsbio Pharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View